The role of PET scanning in the detection of recurrent cervical cancer

Gynecologic Oncology

Volumn 90, Issue 1, 2003, Pages 186-190

  Havrilesky, Laura J ^a,b   Wong, Terence Z ^b   Secord, Angeles Alvarez ^a   Berchuck, Andrew ^a   Clarke Pearson, Daniel L ^a   Jones, Ellen L ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RADIOGRAPHY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; UTERINE CERVIX CANCER; AGED; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MIDDLE AGED; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

ADULT; AGED; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 0038500701     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00256-7     Document Type: Article

References (11)

1. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer Statistics, 2003. CA Cancer J Clin. 53:2003;5-26.
2. Crowe J.P. Jr., Adler L.P., Shenk R.R., Sunshine J. Positron emission tomography and breast masses comparison with clinical, mammographic, and pathological findings . Ann Surg Oncol. 1:(2):1994;132-140.
3. Knight S.B., Delbeke D., Stewart J.R., Sandler M.P. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest. 109:(4):1996;982-988.
4. Rose P.G., Adler L.P., Rodriguez M., Faulhaber P.F., Abdul-Karim F.W., Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging a surgicopathologic study . J Clin Oncol. 17:(1):1999;41-45.
5. Grigsby P.W., Siegel B.A., Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 19:(17):2001;3745-3749.
6. Sugawara Y., Eisbruch A., Kosuda S., Recker B.E., Kison P.V., Wahl R.L. Evaluation of FDG PET in patients with cervical cancer. J Nucl Med. 40:(7):1999;1125-1131.
7. Reinhardt M.J., Ehritt-Braun C., Vogelgesang D., Ihling C., Hogerle S., Mix M., Moser E., Krause T.M. Metastatic lymph nodes in patients with cervical cancer detection with MR imaging and FDG PET . Radiology. 218:(3):2001;776-782.
8. Narayan K., Hicks R.J., Jobling T., Bernshaw D., McKenzie A.F. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer potential impact on treatment . Int J Gynecol Cancer. 11:(4):2001;263-271.
9. Sun S.S., Chen T.C., Yen R.F., Shen Y.Y., Changlai S.P., Kao A. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Anticancer Res. 21:(4B):2001;2957-2961.
10. Parkin D.M., Bray F.I., Devesa S.S. Cancer burden in the year 2000. The global picture. Eur J Cancer. 37:(Suppl 8):2001;S4-66.
11. Grigsby P.W., Siegel B.A., Dehdashti F., Mutch D.G. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiation Oncol Biol Phys. 55:(4):2003;907-913.